N-chlorination of phenytoin by myeloperoxidase to a reactive metabolite

This article is cited by 36 publications.

1. Bowen Gong, Shiyu Zhang, Xin Wang, Guangyun Ran, Xiaohong Zhang, Jing Xi, Zhenna Gao, Yuyang Lei, Jie Pan, Ying Liu, Yang Luan, Xinyu Zhang, Ying Peng, Weiwei Li, Jiang Zheng. Inflammation Intensifies Monocrotaline-Induced Liver Injury. Journal of Agricultural and Food Chemistry 2023, 71 (7) , 3433-3443. https://doi.org/10.1021/acs.jafc.2c07939
2. Jinping Gan, Shuguang Ma, Donglu Zhang. Non-cytochrome P450-mediated bioactivation and its toxicological relevance. Drug Metabolism Reviews 2016, 48 (4) , 473-501. https://doi.org/10.1080/03602532.2016.1225756
3. Karen A. Wulfeck-Kleier, Michael D. Ybarra, Thomas F. Speth, Matthew L. Magnuson. Factors affecting atrazine concentration and quantitative determination in chlorinated water. Journal of Chromatography A 2010, 1217 (5) , 676-682. https://doi.org/10.1016/j.chroma.2009.12.012
4. Daniel C. Whitehead, Richard J. Staples, Babak Borhan. A simple and expedient method for the preparation of N-chlorohydantoins. Tetrahedron Letters 2009, 50 (6) , 656-658. https://doi.org/10.1016/j.tetlet.2008.11.091
5. Wei Lu, Jack P. Uetrecht. Peroxidase-Mediated Bioactivation of Hydroxylated Metabolites of Carbamazepine and Phenytoin. Drug Metabolism and Disposition 2008, 36 (8) , 1624-1636. https://doi.org/10.1124/dmd.107.019554
6. E Malle, P G Furtmüller, W Sattler, C Obinger. Myeloperoxidase: a target for new drug development?. British Journal of Pharmacology 2007, 152 (6) , 838-854. https://doi.org/10.1038/sj.bjp.0707358
7. Xiao-Xia Yang, Ze-Ping Hu, Sui Yung Chan, Shu-Feng Zhou. Monitoring drug–protein interaction. Clinica Chimica Acta 2006, 365 (1-2) , 9-29. https://doi.org/10.1016/j.cca.2005.08.021
8. Shufeng Zhou, Eli Chan, Wei Duan, Min Huang, Yu-Zong Chen. Drug Bioactivation Covalent Binding to Target Proteins and Toxicity Relevance. Drug Metabolism Reviews 2005, 37 (1) , 41-213. https://doi.org/10.1081/DMR-200028812
9. Shufeng Zhou. Separation and detection methods for covalent drug–protein adducts. Journal of Chromatography B 2003, 797 (1-2) , 63-90. https://doi.org/10.1016/S1570-0232(03)00399-4
10. Antonio F Machado, William J. Scott, Michael D. Collins. Reactive Oxygen and Nitrogen Species in the Production of Congenital Malformations by Known Teratogenic Agents and Maternal Conditions. 2003, 379-406. https://doi.org/10.1007/0-306-48412-9_20
11. Robert L. Rubin, Anke Kretz-Rommel. Phagocyte-mediated oxidation in idiosyncratic adverse drug reactions. Current Opinion in Hematology 2001, 8 (1) , 34-40. https://doi.org/10.1097/00062752-200101000-00007
12. J. Steven Leeder. Mechanisms of Idiosyncratic Hypersensitivity Reactions to Antiepileptic Drugs. Epilepsia 1998, 39 (s7) https://doi.org/10.1111/j.1528-1157.1998.tb01679.x
13. K Van Derpoorten, J Balzarini, E De Clercq, J.H. Poupaert. Anti-HIV activity of N-1-adamantyl-4-aminophthalimide. Biomedicine & Pharmacotherapy 1997, 51 (10) , 464-468. https://doi.org/10.1016/S0753-3322(97)82327-X
14. Jack P. Uetrecht. Section Review Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Drug-induced lupus: Possible mechanisms and their implications for prediction of which new drugs may induce lupus. Expert Opinion on Investigational Drugs 1996, 5 (7) , 851-860. https://doi.org/10.1517/13543784.5.7.851
15. Peter G. Wells, Louise M. Winn. Biochemical Toxicology of Chemical Teratogenesis. Critical Reviews in Biochemistry and Molecular Biology 1996, 31 (1) , 1-40. https://doi.org/10.3109/10409239609110574
16. Dennis C. Mays, Lew J. Pawluk, Glen Apseloff, W.Bruce Davis, Zhi-Wu She, Arthur L. Sagone, Nicholas Gerber. Metabolism of phenytoin and covalent binding of reactive intermediates in activated human neutrophils. Biochemical Pharmacology 1995, 50 (3) , 367-380. https://doi.org/10.1016/0006-2952(95)00151-O
17. Colin M. Hill, Joseph Lunec, Helen R. Griffiths, Karl E. Herbert. Characterization of tumour necrosis factor α release by human granulocytes in response to procainamide challenge. Biochemical Pharmacology 1995, 49 (12) , 1837-1849. https://doi.org/10.1016/0006-2952(94)00523-O
18. J. P. Uetrecht, S. P. Spielberg. Mechanisms of neutropenia: The role of Neutrophil-specific pathways of drug metabolism. Pharmacoepidemiology & Drug Safety 1993, 2 (S7) , S37-S42. https://doi.org/10.1002/pds.2630020708
19. Angela H. Hofstra, Jack P. Uetrecht. Myeloperoxidase-mediated activation of xenobiotics by human leukocytes. Toxicology 1993, 82 (1-3) , 221-242. https://doi.org/10.1016/0300-483X(93)90066-2
20. Sylvia M. Furst, Jack P. Uetrecht. Carbamazepine metabolism to a reactive intermediate by the myeloperoxidase system of activated neutrophils. Biochemical Pharmacology 1993, 45 (6) , 1267-1275. https://doi.org/10.1016/0006-2952(93)90279-6
21. Jack P. Uetrecht. The Respiratory Burst and Drug Metabolism: Implications for Idiosyncratic Drug Reactions and Antiinflammatory Effects. 1993, 147-154. https://doi.org/10.1007/978-1-4615-9840-4_8
22. M.C.R. Franssen, H.C. van der Plas. Haloperoxidases: Their Properties and Their Use in Organic Synthesis. 1992, 41-99. https://doi.org/10.1016/S0065-2164(08)70252-1
23. T. Yoshida, T. Tabuchi, K. Andoh. Identification of urinary metabolites of human subjects acutely poisoned by p-chloronitrobenzene. Xenobiotica 1992, 22 (12) , 1459-1470. https://doi.org/10.3109/00498259209056696
24. J. P. Uetrecht. The Role of Leukocyte-Generated Reactive Metabolites in the Pathogenesis of Ideosyncratic Drug Reactions. Drug Metabolism Reviews 1992, 24 (3) , 299-366. https://doi.org/10.3109/03602539208996297
25. Stephen P. Spielberg, Neil H. Shear, Marilyn Cannon, Nancy J. Hutson, Kare Gunderson. In-Vitro Assessment of a Hypersensitivity Syndrome Associated with Sorbinil. Annals of Internal Medicine 1991, 114 (9) , 720-724. https://doi.org/10.7326/0003-4819-114-9-720
26. Eibai Lee, Mitsugu Fujita, Kimio Kariya. Stimulation of phagocytosis in rat polymorphonuclear leukocytes by A23187 is accompanied by activation of myeloperoxidase. Biochemical and Biophysical Research Communications 1991, 176 (1) , 364-370. https://doi.org/10.1016/0006-291X(91)90933-X
27. Jack Uetrecht. Metabolism of Drugs by Activated Leukocytes: Implications for Drug-Induced Lupus and Other Drug Hypersensitivity Reactions. 1991, 121-132. https://doi.org/10.1007/978-1-4684-5877-0_13
28. J. Uetrecht. The role of N-oxidation by leukocytes in drug-induced agranulocytosis and other drug hypersensitivity reactions. 1991, 435-453. https://doi.org/10.1007/978-94-011-3112-4_25
29. Daniel Schlenk, Paz Garcia Martinez, David R. Livingstone. Studies on myeloperoxidase activity in the common mussel, Mytilus edulis L.. Comparative Biochemistry and Physiology Part C: Comparative Pharmacology 1991, 99 (1-2) , 63-68. https://doi.org/10.1016/0742-8413(91)90076-6
30. Mark A. Sanner, Terry J. Higgins. Chapter 19. Chemical Basis for Immune Mediated Idiosyncratic Drug Hypersensitivity. 1991, 181-190. https://doi.org/10.1016/S0065-7743(08)61206-3
31. Christopher A. Lipinski, Jon Bordner, Garth C. Butterfield, Lilian C. Marinovic. N ‐chlorination of dilantin and sorbinil. Journal of Heterocyclic Chemistry 1990, 27 (6) , 1793-1799. https://doi.org/10.1002/jhet.5570270651
32. David A. Eastmond, Martyn T. Smith. [61] Xenobiotic activation by stimulated human polymorphonuclear leukocytes and myeloperoxidase. 1990, 579-585. https://doi.org/10.1016/0076-6879(90)86153-M
33. B. Kevin Park, Neil R. Kitteringham. Drug-Protein Conjugation and its Immunological Consequences. Drug Metabolism Reviews 1990, 22 (1) , 87-144. https://doi.org/10.3109/03602539008991445
34. Jack Uetrecht. Drug Metabolism by Leukocytes and Its Role in Drug-Induced Lupus and Other Idiosyncratic Drug Reactions. Critical Reviews in Toxicology 1990, 20 (4) , 213-235. https://doi.org/10.3109/10408449009089863
35. Jack Uetrecht. Mechanism of hypersensitivityreactions: proposed involvement of reactive metabolites generated by activated leukocytes. Trends in Pharmacological Sciences 1989, 10 (11) , 463-467. https://doi.org/10.1016/S0165-6147(89)80012-4
36. RJ Riley, NR Kitteringham, BK Park. Structural requirements for bioactivation of anticonvulsants to cytotoxic metabolites in vitro.. British Journal of Clinical Pharmacology 1989, 28 (4) , 482-487. https://doi.org/10.1111/j.1365-2125.1989.tb03530.x